[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.3% 4.25 4.10 4.40 4.35 4.25 4.35 386,305 15:56:51
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 11.2 1.0 0.2 21.3 19

Byotrol Share Discussion Threads

Showing 12301 to 12321 of 12325 messages
Chat Pages: 493  492  491  490  489  488  487  486  485  484  483  482  Older
DateSubjectAuthorDiscuss
28/9/2021
21:30
supernumerary - loaf means that before today, that page on the website had a "last updated" tag of December 2020. I know this because I checked it yesterday as I was expecting it to be updated when the annual report was published. So the list may have been updated on 22nd September 2021, but it wasn't published to the website until today (or late yesterday).
1gw
28/9/2021
18:20
Oh dear, I do sense current shareholders are not happy, I think I will give this a miss having watched for a while, patience I feel has paid off, particularly when there are more solid places to invest All I see is lack of growth, lack of news flow, poor sentiment, falling share price, but great potential, however the potential is not enough without the other Good luck all holders, I really do hope it works out for you
stevesham
28/9/2021
14:16
There's no TR1 for Lee, which implies that he's still selling. Which in turn implies the knife is still falling...
supernumerary
28/9/2021
13:51
Annual report has been uploaded to the site and the major shareholders page on the website has been updated. Unfortunately they tell different stories. Annual report shows holdings from August ("As at 18 August 2021, the Company had received notification...") This shows: No significant holding by the Newlands 20.4m shares (4.6%) held by Lim Teck Lee No significant holding by Craig Andrew Weatherhead The website apparently shows a later position ("Last updated 22nd September 2021") and shows: 25m shares (5.5%) holding by the Newlands No significant holding by Lim Teck Lee 15.8m shares (3.5%) holding by Craig Andrew Weatherhead My guess is that the AR numbers are both out-of-date and wrong (The Newlands declared 4.4% voting rights held as shares (plus 0.6% spreadbet) as of 26th April 2021 and then 5.4% shares (plus 0.7% spreadbet) as of 19th August). So assuming that the website is correct, the major news there is that it no longer shows Lim Teck Lee as a significant shareholder. If he has sold down, at least below the 3% level, and perhaps has more to go that would perhaps account for some of the share price weakness.
1gw
28/9/2021
12:03
LOL! yet again -0.05 down
football
27/9/2021
20:59
Pug when they did that results call DT said the borad sold there shares to II's
football
27/9/2021
19:47
Hi- LOB - Where did you find details of Directors dumping I can see options beign granted and then then sold - April 2021 But rns's over last 18 months show then buying buying in the market not selling - eg:"24 September 2020 that on that same day, Nic Hellyer, CFO of the Company, purchased 129,870 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 7.7p " "on 30 January 2020, John Langlands, Non-Executive Chairman of the Company, and Nic Hellyer, Chief Financial Officer of the Company, purchased 1,000,000 and 500,000 ordinary shares of 0.25p each ("Ordinary Shares") respectively at prices between 1.79 and 1.83 pence per Ordinary Share
pugugly
27/9/2021
17:19
I wish I dumped my stock at 7p like most of the BOD. Serves me right for actually engaging with the company and listening to what they said.
loafofbread
27/9/2021
17:09
Still 3 days left to get a good IP deal into 1H. Onwards and upwards.
1gw
27/9/2021
16:38
AGM 20th October at last
football
27/9/2021
09:48
I'm betting that they are delaying the AGM as long as possible hoping we go into a second lockdown so then I don't have to meet shareholders.
football
26/9/2021
17:30
1gw "finnCap estimated "these royalties could rise to c. £5m+ for Actizone alone in the next 5 years" "COULD" "NEXT 5 YEARS" still jam tomorrow. How many years ago did they make the Solvay agreement? Wasn't it 2018? As predicted, where there's demand for a product, other companies adapt and enter the market, which is exactly what has happened. End of Sept (end of H1) this week. When is the AGM?
sikhthetech
25/9/2021
13:10
The other thing that I think argues against betting too big on byotrol's own Actizone sales is the Solvay agreement, under which byotrol receives royalties on Solvay's Actizone sales. You might not want to bet the company on too big a marketing campaign for hycolin 24 in the near-term if you thought there was a chance that the Solvay deal could start bringing in several million of profit before long (finnCap estimated "these royalties could rise to c. £5m+ for Actizone alone in the next 5 years").
1gw
25/9/2021
12:09
Thank you 1gw I will stand corrected and I appreciate the points you make, I value your input and will continue to watch with keen interest, if as you say all the above is being done and there is a passion, I just don't know what is keeping the share price flat/depressed, maybe it is just the market doesn't like them or understand the potential right now. I have the same sentiment with another company that I do hold shares in where the future and potential is fantastic, they are profitable and have cash and the board are aligned with shareholders by the number of shares they own, but still the price remains flat at best Funny old thing the market, you can't fight it, have to roll with the good and not so good Good luck, hoping to join you soon
stevesham
25/9/2021
10:50
Stevesham - a lot of this is happening already. UK & Ireland hospitals are covered by the Tristel deal which is exclusive there (and non-exclusive elsewhere). Byotrol is supplying Actizone (in concentrate form) for dispensing via Tristel's Cache system. They are also developing a new product which combines Tristel's sporicidal (chlorine dioxide) chemistry with byotrol's Actizone-based long-lasting antimicrobial technology. hTtps://byotrolplc.com/wp-content/uploads/2020/03/2020-03-20-Byotrol-RNS-re-Tristel-FINAL-pdf.pdf They also already have a European deal with Turtle Wax, which puts Actizone into Halfords (positioned as an automotive cleaning/disinfecting product) in the UK and will put it into other European Turtle Wax outlets. hTtps://byotrolplc.com/wp-content/uploads/2021/04/2021-04-21-TU-approved-pdf.pdf They now have Hycolin 24 which appears aimed at both professional and consumer UK markets. And they still have their own-branded byotrol 4-in-1 which is (I understand) Actizone, with a reasonable positioning in professional markets - have you come across this? but I suspect byotrol 4-in-1 might be dropped in favour of Hycolin 24 branding if this product launches successfully. They have a number of products sold through Pets At Home and according to the recent Investor Meet Company presentation, at least one of the Pets At Home products is Actizone-based. hTtps://www.petsathome.com/shop/en/pets/searchterm?searchTerm=byotrolproducts&pageSize=24&resultType=1 In the US they have byotrol 24, which is not Actizone-based, but also has 24 hour claims with EPA registration. Solvay are progressing Actizone registration with the EPA and byotrol will have the option to launch an Actizone product there, I presume, once that registration is achieved, although they will no doubt consider how that would impact their existing US agreement with IRI for byotrol 24. So personally, I don't think the board lack energy, vision or passion for Actizone, but they are limited by the resources they have available as a small company with not many employees. They also are very protective, I think, of the company's resources and given byotrol's past near-death experience before DT took over, I imagine they would think long and hard before considering taking on anything like private equity-type levels of debt to go really big and early on hycolin 24. In terms of "not listening to shareholders" I don't think that's fair either. DT is one of the most approachable CEO's I've come across. My criticism isn't that the board doesn't listen to or isn't approachable by individual shareholders, it is that it doesn't as a matter of course communicate particularly well with retail shareholders in aggregate (through the website, RNS, frequency of presentation). I think the board has taken the view that the company ultimately will succeed or fail based on the strength of its products and its business development, and that given their limited resources they should minimise "non-core" activity. With that mindset, you can listen to retail shareholders saying they want more communication, but you still have to make a judgement call on how much resource you are willing to divert from "core" business development activity to shareholder communication.
1gw
25/9/2021
09:48
In my humble opinion, this is what I believe Byotrol 24hour should do assuming that their 24 hour claims can be independently substantiated and questions answered 1. Identify what the product actually cleans, is it just protection after a clean as with some sanitisers/viricides. 2. I was always trained that you needed to clean surfaces to remove dirt before you can sanitise/disinfect 3. If it does clean, what does it clean, grease, limescale, general dirt, soap scum, body fat etc etc? 4. Can the product be added to other cleaning chemicals relevant to their application? 5. How strong is the IP/Patent and what territories, just UK, Global etc 6. Could the product be produced as a powder as an additive to cleaning/laundry tabs, and other powders? If the answers to the above are positive, then they need to spend some serious time and effort (not so much money) talking and putting deals together with all the second tier chemical manufacturers not the P&G/Unilever although that would be nice, but I would suggest their lab teams could develop their own easily, by second tier manufacturers, I mean the likes of Selden Research HTTPS://www.selden.co.uk/ Clover Chemicals HTTPS://www.cloverchem.co.uk/2013/uk/index_uk.asp Greyland HTTPS://www.greyland.co.uk/ McBride HTTPS://www.mcbride.co.uk/ and others, we know about Mirius and Deb (SC Johnson) so with just these few, we could be talking about a significant pipeline of opportunity, these manufacturers not only sell into Janitorial Distributors, and some into retail, but also produce "own label" products for many brands, particularly McBride My question is, and maybe I should ask the board, but from what I understand, they don't listen to shareholders (I am not one anyway yet) why has this already not been done, it's not difficult if the products stack up, it really isn't, and let's not mention about what is being done with Infection control in the NHS. It's crazy, I do wonder if the board have a lack of energy, vision or passion for what should be a world leading product. It is so frustrating for me as the opportunity is massive, but not for me yet
stevesham
25/9/2021
09:08
What would private equity do with such a product in such a situation?
1gw
25/9/2021
09:05
It must be a really interesting sales and marketing discussion around Hycolin 24. On the one hand they have price pressure from the P&G and Unilever 24 hour products as those companies try to establish a position. On the other hand they have what they believe is a superior product (robust 24 hour anti-viral protection) and they have P&G and Unilever helping to condition the market to consider residual protection products. And they have a window of opportunity for Hycolin 24 to establish itself before Solvay's global customers launch equivalent products - on the assumption that those customers are waiting for Solvay to get its EPA registration through before launching new global products.
1gw
25/9/2021
06:56
1gw All great points, thank you, I will know a lot more about the Hycolin product over the coming weeks and months, so if anything else becomes apparent and is useful both positively (hopefully) or not so, I will post it here. Just for info the test results, contact times and log results are checked, certainly in the professional sector by Environmental Health Officers on their routine inspections of catering establishments, and by Infection Control Nurses in Hospitals which are both massive users of this type of product. Let's see what the coming weeks/months bring
stevesham
24/9/2021
22:00
The problem is we have a management that can get us from Division 3 to the premier League but not into the champions League
football
24/9/2021
20:38
Stevesham - There's quite a bit of detail in the paper about test methods, and I guess it will mean more to you than it does to me. There's a 10 minutes associated with the "residual" bit of the tests themselves (log 3 reduction within 10 minutes of a viral challenge) so whether the 10 minutes in the bit I quote above is referring to the initial contact time when Actizone is first applied, or 10 minutes after a viral challenge during the residual test, I'm not quite sure. But I think the fact that Solvay are making such a big deal of Actizone means they are excited about its potential for professional as well as consumer environments. "Unlike existing virucidal standards, both of these methods subject the disinfectant-treated surface to multiple cycles of alternating wet and dry wiping (abrasions) each interspersed with a challenge consisting of at least 3-4 log10 virus particles. In order to meet the regulatory requirements, the test surface would need to demonstrate a minimum of 3 log10 or 99.9% reduction of the final viral challenge within 10 minutes of exposure."
1gw
Chat Pages: 493  492  491  490  489  488  487  486  485  484  483  482  Older
ADVFN Advertorial
Your Recent History
LSE
BYOT
Byotrol
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210928 21:00:20